Am J Cancer Res
- NAGATA Y, Goto T, Teramoto Y, Matsukawa T, et al
Mineralocorticoid receptor signaling inhibits bladder cancer progression.
Am J Cancer Res. 2024;14:696-708.
Ann Surg Oncol
- DASON S, Lee CT
Paradigm Shifting Research: Key Studies in Urologic Oncology.
Ann Surg Oncol. 2024;31:2529-2537.
- MILOJEVIC B, Janicic A, Grozdic Milojevic I, Grubor N, et al
Prognostic Impact of Preoperative Thrombocytosis on Recurrence-Free Survival in
Patients with Upper Tract Urothelial Carcinoma.
Ann Surg Oncol. 2024;31:2538-2544.
Anticancer Res
- SHINDO T, Hashimoto K, Takahashi A, Miyamoto S, et al
Comparison of Oncological Outcomes of Pembrolizumab as Second-line Therapy and
Maintenance Avelumab Therapy in Advanced Urothelial Carcinoma After
Platinum-based Chemotherapy.
Anticancer Res. 2024;44:1271-1279.
Appl Immunohistochem Mol Morphol
- KAPAGANTI VK, Purkait S, Nayak P, Biswas D, et al
Diminution of Primary Cilia in the Stromal Cells at the Tumor-stromal Interface
Correlates With an Aggressive Tumor Biology in the Urothelial Carcinoma of the
Urinary Bladder.
Appl Immunohistochem Mol Morphol. 2024;32:130-136.
Arch Ital Urol Androl
- DJATISOESANTO W, Azmi YA, Yatindra IBGTY
The relationship between income, health insurance, and employment status as
prognostic indicators of bladder cancer: a survival analysis.
Arch Ital Urol Androl. 2024 Mar 7:12305. doi: 10.4081/aiua.2024.12305.
Biochim Biophys Acta Mol Basis Dis
- CHEN KC, Dhar T, Chen CR, Chen CY, et al
Nicotinamide phosphoribosyltransferase modulates PD-L1 in bladder cancer and
enhances immunotherapeutic sensitivity.
Biochim Biophys Acta Mol Basis Dis. 2024 Feb 28:167106.
Bioeng Transl Med
- XIONG Q, Liu T, Ying Y, Yu X, et al
Establishment of bladder cancer spheroids and cultured in microfluidic platform
for predicting drug response.
Bioeng Transl Med. 2023;9:e10624.
Biomaterials
- QI F, Bao Q, Hu P, Guo Y, et al
Mild magnetic hyperthermia-activated immuno-responses for primary bladder cancer
therapy.
Biomaterials. 2024;307:122514.
BMC Med Res Methodol
- ODURO MS
A Bayesian Bernoulli-Exponential joint model for binary longitudinal outcomes and
informative time with applications to bladder cancer recurrence data.
BMC Med Res Methodol. 2024;24:54.
Br J Cancer
- OUYANG Y, Zhong W, Xu P, Wang B, et al
Tumor-associated neutrophils suppress CD8(+) T cell immunity in urothelial
bladder carcinoma through the COX-2/PGE2/IDO1 Axis.
Br J Cancer. 2024;130:880-891.
Cancer Cytopathol
- ALHAMAR M, Al-Ahmadie HA, Feratovic R, Lin O, et al
Sensitivity of urine cytology in detecting high-grade urothelial carcinoma in
patients with neoplastic urinary bladder diverticula: A major cancer center
experience.
Cancer Cytopathol. 2024;132:144-151.
- LI JJX, Ng JKM, Tang CY, Chan BCH, et al
Urine cytology in the detection of renal cell carcinomas - a territory-wide
multi-institutional retrospective review of more than 2 decades.
Cancer Cytopathol. 2024;132:186-192.
Cancer Genomics Proteomics
- OKUDA Y, Kato T, Fujita K, Fushimi H, et al
Association of Androgen Receptor and PD-L1 Expression in Upper Urinary Tract
Urothelial Carcinoma.
Cancer Genomics Proteomics. 2024;21:137-143.
Cancer Immunol Immunother
- LI B, Jin K, Liu Z, Su X, et al
Integrating molecular subtype and CD8(+) T cells infiltration to predict
treatment response and survival in muscle-invasive bladder cancer.
Cancer Immunol Immunother. 2024;73:66.
Cancer Immunol Res
- ZHANG H, Lee S, Muthakana RR, Lu B, et al
Intragenic Rearrangement Burden Associates with Immune Cell Infiltration and
Response to Immune Checkpoint Blockade in Cancer.
Cancer Immunol Res. 2024;12:287-295.
Cancer Med
- BARCENA PGQ, Aprikian AG, Dragomir A
Secondary bladder and colorectal cancer after treatments for prostate cancer: A
population based study.
Cancer Med. 2024;13:e6922.
- LIU G, Jin K, Liu Z, Su X, et al
POLQ identifies a better response subset to immunotherapy in muscle-invasive
bladder cancer with high PD-L1.
Cancer Med. 2024;13:e6962.
Cancer Res
- HOSNI S, Kilian V, Klumper N, Gabbia D, et al
Adipocyte Precursor-Derived NRG1 Promotes Resistance to FGFR Inhibition in
Urothelial Carcinoma.
Cancer Res. 2024;84:725-740.
Clin Genitourin Cancer
- SZCZESNIEWSKI JJ, Marquez-Sanchez MT, Padilla-Fernandez B, Llanes-Gonzalez L, et al
Recurrent Bacteriuria as a Prognosis Marker in the Adjuvant Treatment of
Non-Muscle Invasive Bladder Cancer.
Clin Genitourin Cancer. 2024;22:102048.
Comput Biol Med
- HAO S, Shen L, Liu P, Yong Q, et al
Development of a prognostic model for muscle-invasive bladder cancer using
glutamine metabolism.
Comput Biol Med. 2024;171:108223.
Diagn Cytopathol
- KANNAN N, Gochhait D, Ramanitharan M, Siddaraju N, et al
A comparison between conventional and the Paris systems of reporting urinary
cytopathology with a literature update.
Diagn Cytopathol. 2024;52:187-199.
Discov Oncol
- KONG YL, Wang HD, Gao M, Rong SZ, et al
LncRNA XIST promotes bladder cancer progression by modulating miR-129-5p/TNFSF10
axis.
Discov Oncol. 2024;15:65.
Enferm Infecc Microbiol Clin (Engl Ed)
- RAICES FRANCISCO N, Suarez Gil R, Ayuso Garcia B, Romay Lema E, et al
BCGitis with aortoiliac aneurysm involvement: Report of two cases and review of
the literature.
Enferm Infecc Microbiol Clin (Engl Ed). 2024;42:152-157.
Front Immunol
- HUANG Y, Liao C, Shen Z, Zou Y, et al
A bibliometric insight into neoadjuvant chemotherapy in bladder cancer: trends,
collaborations, and future avenues.
Front Immunol. 2024;15:1297542.
Future Oncol
- LORIOT Y, O'Hagan A, Siefker-Radtke AO
Plain language summary of erdafitinib in locally advanced or metastatic
urothelial carcinoma: a phase 2 study with long-term follow-up.
Future Oncol. 2024;20:231-243.
Genes Genomics
- LIU Y, Zou SH, Gao X
Bioinformatics analysis and experimental validation reveal that CDC20
overexpression promotes bladder cancer progression and potential underlying
mechanisms.
Genes Genomics. 2024 Mar 4. doi: 10.1007/s13258-024-01505.
Hinyokika Kiyo
- OSHIRO H, Shimizu Y, Nakayasu R, Yamaguchi R, et al
[Bladder Cancer Detected Incidentally by Cystoscopy before Radical
Prostatectomy].
Hinyokika Kiyo. 2024;70:39-43.
IJU Case Rep
- MITANI K, Tsuboi I, Tanaka G, Yosioka S, et al
Metastatic small cell bladder cancer treated with sequential systemic therapy
including pembrolizumab and amrubicin: A case report.
IJU Case Rep. 2023;7:127-130.
Int J Radiat Biol
- WANG Q, Zhang R, He Y, Mao G, et al
Taraxasterol enhanced bladder cancer cells radiosensitivity via inhibiting the
COX-2/PGE2/JAK2/STAT3/MMP pathway.
Int J Radiat Biol. 2024 Mar 5:1-11. doi: 10.1080/09553002.2024.2324475.
J Cancer
- WEI H, Cheng X, Wang G, Li Z, et al
Causal association of smoking, blood lipids, and bladder cancer: Insights from a
multivariable and mediation mendelian randomization investigation.
J Cancer. 2024;15:1929-1939.
J Cell Mol Med
- FU Y, Sun S, Shi D, Bi J, et al
Construction of endothelial cell signatures for predicting the diagnosis,
prognosis and immunotherapy response of bladder cancer via machine learning.
J Cell Mol Med. 2024;28:e18155.
J Chemother
- ABOU CHAKRA M, Moussa M, O'Donnell MA
Intravesical sequential gemcitabine/docetaxel for non-muscle invasive bladder
cancer: tips and tricks for better efficacy and tolerability.
J Chemother. 2024 Mar 4:1-4. doi: 10.1080/1120009X.2024.2325765.
J Int Med Res
- HUANG XL, Sun Y, Wen P, Pan JC, et al
The potential mechanism of ursolic acid in the treatment of bladder cancer based
on network pharmacology and molecular docking.
J Int Med Res. 2024;52:3000605241234006.
JAMA Netw Open
- MAIORANO BA, Di Maio M, Cerbone L, Maiello E, et al
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune
Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
JAMA Netw Open. 2024;7:e241215.
Microbiome Res Rep
- PENG Z, Zhuang J, Shen B
The role of microbiota in tumorigenesis, progression and treatment of bladder
cancer.
Microbiome Res Rep. 2023;3:5.
Minerva Urol Nephrol
- BASILE G, Gallioli A, Martini A, Verri P, et al
Oncologic surveillance intensity after endoscopic treatment of upper tract
urothelial carcinoma.
Minerva Urol Nephrol. 2024;76:88-96.
Mol Carcinog
- ZHANG Q, Wang L, Yu L, Yu Q, et al
Tectoridin inhibits the growth of bladder cancer by regulating PI3K/MAPK pathway
through RAB27B.
Mol Carcinog. 2024 Mar 5. doi: 10.1002/mc.23712.
N Engl J Med
- NIEGISCH G
Enfortumab Vedotin and Pembrolizumab - A New Perspective on Urothelial Cancer.
N Engl J Med. 2024;390:944-946.
- POWLES T, Valderrama BP, Gupta S, Bedke J, et al
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer.
N Engl J Med. 2024;390:875-888.
Nutr Cancer
- CHEN YT, Tang QY, Zhang YX, Wang SZ, et al
An Atlas of Dietary Intakes and Medication Uses on Risk of Bladder Cancer: A
Wide-Angle Mendelian Randomization Analysis.
Nutr Cancer. 2024 Mar 5:1-10. doi: 10.1080/01635581.2024.2324504.
Oncologist
- MUQUITH M, Hsiehchen D
Landscape and Saturation Analysis of Mutations Associated With Race in Cancer
Genomes by Clinical Sequencing.
Oncologist. 2024;29:219-226.
- GUPTA S, Costantino H, Ike C, Gupta S, et al
Evaluating Oncologists' Practice Patterns and Decision-Making in Locally Advanced
or Metastatic Urothelial Carcinoma: The US Physician PARADIGM Study.
Oncologist. 2024;29:244-253.
Photodiagnosis Photodyn Ther
- XU Q, Li T, Lin J, Wu X, et al
Label-free screening of common urinary system tumors from blood plasma based on
surface-enhanced Raman spectroscopy.
Photodiagnosis Photodyn Ther. 2024;45:103900.
Radiographics
- HOEGGER MJ
Invited Commentary: VI-RADS and Routing Patient Care at the Muscularis Propria.
Radiographics. 2024;44:e230234.
- FAVERO PRIETTO DOS SANTOS J, Ghezzi CLA, Pedrollo IM, Cruz IR, et al
Practical Guide to VI-RADS: MRI Protocols, Lesion Characterization, and Pitfalls.
Radiographics. 2024;44:e230149.
Sex Med
- NOLTING J, Nitzsche R, Kiss B, Hakenberg OW, et al
Prospective evaluation of sexual health following radical cystectomy due to
bladder cancer.
Sex Med. 2024;12:qfae005.
Toxicol Appl Pharmacol
- CHEN J, Fan S, Guo J, Yang J, et al
Discovery of anticancer function of Febrifugine: Inhibition of cell
proliferation, induction of apoptosis and suppression steroid synthesis in
bladder cancer cells.
Toxicol Appl Pharmacol. 2024;484:116878.
Urol Oncol
- COOKE I, Abou Heidar N, Mahmood AW, Ahmad A, et al
The role of neoadjuvant chemotherapy for patients with variant histology muscle
invasive bladder cancer undergoing robotic cystectomy: Data from the
International Robotic Cystectomy Consortium.
Urol Oncol. 2024 Feb 29:S1078-1439(24)00002.
Urology
- LIBLIK K, Queen JC, Touma NJ
Immune Checkpoint Inhibitors for Kidney and Bladder Cancer: Adrenotoxic
Consequences.
Urology. 2024 Feb 29:S0090-4295(24)00129-8. doi: 10.1016/j.urology.2024.
- LEPOR H, Wiegand L, Patel K, Du W, et al
A Randomized Clinical Trial Evaluating Indigo Carmine as a Visualization Aid for
Evaluating Ureteral Patency.
Urology. 2024;184:105-111.
- WEISS K, Abimbola O, Miller K, Kim WY, et al
Near Complete Response to Platinum-based Systemic Chemotherapy in High-risk Upper
Tract Urothelial Carcinoma With an ERBB2 Gene Mutation: A Case Report.
Urology. 2024;184:75-78.
World J Clin Oncol
- ZHOU SQ, Luo LX
TM9SF1 is implicated in promoting the proliferation and invasion of bladder
cancer cells.
World J Clin Oncol. 2024;15:175-177.
- WEI L, Wang SS, Huang ZG, He RQ, et al
TM9SF1 promotes bladder cancer cell growth and infiltration.
World J Clin Oncol. 2024;15:302-316.
World J Urol
- LI M, Nandurkar R, Toniolo J, Davis ID, et al
A phase 2 pilot study of water irrigation after transurethral resection of
bladder tumor (WATIP) demonstrating safety, feasibility and activity.
World J Urol. 2024;42:115.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016